Results 261 to 270 of about 1,472,669 (399)

Isavuconazole: Need for therapeutic drug monitoring and CYP polymorphism testing. [PDF]

Med Mycol Case Rep
Soman R, Mayya S, Doshi R, Singh I, Ganpule S.   +4 more
europepmc   +1 more source

Association of CDKN2A/B Homozygous Deletion and Extent of Resection With Survival of Patients With WHO CNS5 Grade 4 Astrocytoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives WHO grade 4 astrocytomas are associated with poor prognosis, and their prognostic factors remain controversial. This study aimed to identify the prognostic factors and develop a management algorithm for these patients. Methods This study retrospectively included 151 CNS5 adult grade 4 astrocytomas from two medical centers.
Jiawei Cai, Guanglin Zhu, Qiu He, Chen Luo, Lingyun Zhuo, Xingfu Wang, Yiming Chen, Xiaoyong Chen, Wendong You, Jiaheng Xu, Yuanxiang Lin, Dezhi Kang, Shuai Wu, Zanyi Wu   +13 more
wiley   +1 more source

Saliva Based Clozapine Therapeutic Drug Monitoring: A Systematic Review. [PDF]

Pharmacol Res Perspect
Rademaker T, Chu R, Hasan S, Harris A, Alffenaar JW.   +4 more
europepmc   +1 more source

135 Therapeutic drug monitoring (TDM) in adult patients receiving imipenem (IMP) or cefepime (CEF) therapy: One-year single-center experience

, 2006
Soor Rajiv Vora, A.A. Pascual, S. Bolay, P Francioli, Thierry Calandra, Oscar Marchetti   +5 more
openalex   +1 more source

Spinal Cord Infarction Versus Idiopathic Transverse Myelitis: Clinical, Radiological, and Functional Insights From a Retrospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Spinal cord infarction (SCI) is a rare but devastating myelopathy, characterized by a high disability rate and an unfavorable prognosis. It has often been underdiagnosed and misdiagnosed as idiopathic transverse myelitis (ITM). This study aimed to describe the clinical features, radiological biomarkers, treatments, and functional ...
Zeqiang Ji, Jianlong Zhang, Yiming Shi, Shiyu Shan, Yang Du, Guangshuo Li, Ying Jin, Yani Zhang, Chuanying Wang, Yijun Lin, Yuhao Guo, Decai Tian, Xingquan Zhao, Tian Song   +13 more
wiley   +1 more source

Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application. [PDF]

Front Pharmacol
Zhao YC, Liu JY, Li JK, Liu HY, Sun ZH, Zhang BK, Yan M.   +6 more
europepmc   +1 more source

Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan, Elizabeth I. Pierpont, Amena S. Fine, Reena V. Kartha   +3 more
wiley   +1 more source

Toward personalized therapeutic drug monitoring of ustekinumab in Crohn's disease: influence of previous exposure to biologics. [PDF]

Therap Adv Gastroenterol
Kwon Y, Kim YZ, Jeong TJ, Kim SY, Kim H, Kim ES, Choe YH, Kim MJ.   +7 more
europepmc   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Therapeutic drug monitoring plays an important role in patients with noninfectious uveitis receiving adalimumab. [PDF]

Front Immunol
Cheng W, Xiao J, Li S, Wang H, Wang S, Qian Y, Zhao C, Gao F, Qin X, Zhang M.   +9 more
europepmc   +1 more source